Study finds combination therapy suppresses pancreatic tumor growth in mice
Genetic variants for skin color in African Americans linked to vitamin D deficiency
18 February 2021Spotting an eating disorder in your college-age child
18 February 2021Study finds combination therapy suppresses pancreatic tumor growth in mice
UCLA Jonsson Comprehensive Cancer Center researchers have uncovered a potential new way to target pancreatic tumors that express high intratumoral interferon signaling (IFN). The team found that high type I IFN signaling is present in a subset of pancreatic tumors and it triggers a decrease in the level of NAD and NADH in pancreatic cancer cells, which are vital cofactors in critical metabolic processes.
